Portuguese 
English 
Spanish 
2 min of reading 
0 comments 
UFC Transfers Patent and Tilapia Skin Dressing Will Arrive at Hospitals with Industrial Production Expected to Start by 2027.
The industrial production of the innovative biological dressing made with tilapia skin is set to transform burn treatment in Brazil.
This advancement is made possible because UFC (Federal University of Ceará) has transferred the patent of the technology for commercial use.
The technology, developed within the university since 2015, will now be managed by the pharmaceutical industry, in a move that solidifies the partnership between academia and the productive sector.
-
Mysterious object on Mars divides NASA and Harvard after Curiosity image reignites suspicions about what was really found on the planet.
-
Giant structures 14 meters beneath Egypt are revealed by satellites and expose a millennia-old secret buried in Buto.
-
Children have been making clay pieces for 15,000 years in Southwest Asia, and fingerprints preserved on 142 ornaments helped archaeologists prove this.
-
New semi-autonomous legged robot technology challenges the limitations of space exploration by operating almost without human intervention on the Moon.
Patent Transferred and Tilapia Skin Dressing Will Reach Hospitals Nationwide
The decision to transfer the patent ensures the industrial and commercial use of the technology, something considered essential by UFC researchers.
The dressing made with tilapia skin is expected to finally reach hospitals and specialized centers, expanding access to treatments that have already shown significant results in controlled studies.
Biotec Wins Public Bid and Begins Plan to Industrialize the Dressing
The winning company of the licensing process was Biotec, a pharmaceutical company with 32 years of experience and direct support for research since 2018.
The technology also has applications in other types of injuries, such as vaginal reconstructions for patients undergoing radiotherapy.
University Transfers Patent and Tilapia Skin Dressing Will Arrive at Hospitals with Million-Unit Production
With the signing of the agreement, UFC and the inventors of the method will receive R$ 850,000, in addition to 3.7% royalties on the factory’s net profit.
The initial projection from Biotec indicates the production of 1 million units of tilapia skin in the first year.
Factory Expected to Begin Operations by the End of 2027
Biotec estimates that the factory will start operations by the end of 2027, after completing construction and setting up the industrial plant.
With this new phase, experts believe that Brazil will establish itself as a global reference in the use of tilapia skin for clinical purposes.
Seja o primeiro a reagir!